Clinical Research in Cardiology Supplements

2.0(top 20%)

impact factor

151(top 50%)

papers

888(top 50%)

citations

17(top 50%)

h-index

2.1(top 20%)

extended IF

217

all documents

925

doc citations

27(top 50%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies	Clinical Research in Cardiology Supplements	2017	87
2	Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis	Clinical Research in Cardiology Supplements	2012	75
3	PCSK9 targets important for lipid metabolism	Clinical Research in Cardiology Supplements	2017	46
4	Current view: indications for extracorporeal lipid apheresis treatment	Clinical Research in Cardiology Supplements	2012	43
5	Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects	Clinical Research in Cardiology Supplements	2015	41
6	Role of lipid apheresis in changing times	Clinical Research in Cardiology Supplements	2012	37
7	The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on	Clinical Research in Cardiology Supplements	2017	34
8	Manual zur Indikation und Durchführung der Echokardiographie	Clinical Research in Cardiology Supplements	2009	32
9	Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region	Clinical Research in Cardiology Supplements	2019	31
10	Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels	Clinical Research in Cardiology Supplements	2019	24
11	Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss	Clinical Research in Cardiology Supplements	2012	19
12	Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines	Clinical Research in Cardiology Supplements	2017	19
13	Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R)	Clinical Research in Cardiology Supplements	2012	18
14	Lipid apheresis: oxidative stress, rheology, and vasodilatation	Clinical Research in Cardiology Supplements	2012	17
15	Lipoprotein(a)—clinical aspects and future challenges	Clinical Research in Cardiology Supplements	2015	15
16	Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease	Clinical Research in Cardiology Supplements	2015	14
17	Lipoprotein(a)—antisense therapy	Clinical Research in Cardiology Supplements	2019	14
18	HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures	Clinical Research in Cardiology Supplements	2012	13
19	Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels	Clinical Research in Cardiology Supplements	2015	13
20	Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors	Clinical Research in Cardiology Supplements	2019	12
21	Incidence of elevated lipoprotein (a) levels in a large cohort of patients with cardiovascular disease	Clinical Research in Cardiology Supplements	2017	11
22	Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results	Clinical Research in Cardiology Supplements	2019	10
23	Is lipoprotein(a) a risk factor for ischemic stroke and venous thromboembolism?	Clinical Research in Cardiology Supplements	2019	9
24	Kidney-specific proteins: markers for detection of renal dysfunction after cardiac surgery?	Clinical Research in Cardiology Supplements	2007	8
25	Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias	Clinical Research in Cardiology Supplements	2015	8
26	Lipoprotein (a) and coronary heart disease – is there an efficient secondary prevention?	Clinical Research in Cardiology Supplements	2017	8
27	Lipoprotein(a) and mortality—a high risk relationship	Clinical Research in Cardiology Supplements	2019	8
28	Gender aspects in patients with angina and unobstructed coronary arteries	Clinical Research in Cardiology Supplements	2013	7
29	Hyperlipoproteinaemia(a) – apheresis and emerging therapies	Clinical Research in Cardiology Supplements	2017	6
30	Lipid apheresis techniques: current status in Germany	Clinical Research in Cardiology Supplements	2012	5
31	Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study	Clinical Research in Cardiology Supplements	2015	5
32	Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)	Clinical Research in Cardiology Supplements	2017	5
33	Lipoprotein(a) in nephrological patients	Clinical Research in Cardiology Supplements	2017	5
34	Pathophysiology of heart failure	Clinical Research in Cardiology Supplements	2010	4
35	Therapeutic apheresis in peripheral and retinal circulatory disorders	Clinical Research in Cardiology Supplements	2012	4
36	Percutaneous aortic valve replacement: results update, future trends and new challenges	Clinical Research in Cardiology Supplements	2009	3
37	Kardiologische Rehabilitation in Europa	Clinical Research in Cardiology Supplements	2009	3
38	Hippocrates of Kos—the father of modern medicine	Clinical Research in Cardiology Supplements	2010	3
39	Riociguat for treatment of pulmonary hypertension	Clinical Research in Cardiology Supplements	2010	3
40	Sex differences and sex hormone effects in long-QT syndrome: what can we learn from rabbit models?	Clinical Research in Cardiology Supplements	2013	3
41	Risk-treatment paradox in women with symptomatic coronary artery disease	Clinical Research in Cardiology Supplements	2013	3
42	The impact of renal dysfunction on early mortality after cardiac surgery	Clinical Research in Cardiology Supplements	2007	2
43	Intra-clinic variation of OPCAB performance influences the incidence of postoperative renal failure	Clinical Research in Cardiology Supplements	2007	2
44	Leitliniengerechte Diagnostik der koronaren Herzerkrankung (KHK) in der Klinik: Grundlagen und Anwendung	Clinical Research in Cardiology Supplements	2007	2
45	Characterization of patients with acute chest pain using cardiac magnetic resonance imaging	Clinical Research in Cardiology Supplements	2010	2
46	Current pulmonary hypertension guidelines and remaining controversies	Clinical Research in Cardiology Supplements	2010	2
47	Genes and hormones: sex differences in myocardial hypertrophy	Clinical Research in Cardiology Supplements	2013	2
48	Lipoprotein(a)-hyperlipoproteinemia as cause of chronic spinal cord ischemia resulting in progressive myelopathy – successful treatment with lipoprotein apheresis	Clinical Research in Cardiology Supplements	2017	2
49	Kardiovaskuläre Erkrankungen bei Patienten mit Nierenerkrankungen	Clinical Research in Cardiology Supplements	2007	1
50	Nieren-Prophylaxe bei thorakaler Aortenchirurgie	Clinical Research in Cardiology Supplements	2007	1

Scientometrics

Overviews

Citing Bodies

Clinical Research in Cardiology Supplements

Top Articles